Literature DB >> 20102155

Current and future medical approaches to combat the anthrax threat.

Dimitrios G Bouzianas1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102155     DOI: 10.1021/jm901024b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  16 in total

1.  Structure of a short-chain dehydrogenase/reductase from Bacillus anthracis.

Authors:  Jing Hou; Kamila Wojciechowska; Heping Zheng; Maksymilian Chruszcz; David R Cooper; Marcin Cymborowski; Tatiana Skarina; Elena Gordon; Haibin Luo; Alexei Savchenko; Wladek Minor
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-24

Review 2.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

3.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

Review 4.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

Review 5.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

Review 6.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 7.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

8.  De novo asymmetric synthesis of oligo-rhamno di- and tri-saccharides related to the anthrax tetrasaccharide.

Authors:  Hua-Yu Leo Wang; Haibing Guo; George A O'Doherty
Journal:  Tetrahedron       Date:  2013-04-22       Impact factor: 2.457

Review 9.  An overview of anthrax infection including the recently identified form of disease in injection drug users.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2012-04-24       Impact factor: 17.440

10.  Tetrazole-Based trans-Translation Inhibitors Kill Bacillus anthracis Spores To Protect Host Cells.

Authors:  John N Alumasa; Tyler D P Goralski; Kenneth C Keiler
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.